RioGin is Drug Discovery in United States that focus on therapeutic drugs business. Founded in 2013. They cover business area such as developer, peptide therapeutic drug, their pharmacodynamic property, their proprietary platform technology, life, convenient dosing, reduce side effect, well compliance, patient, well treatment, low dosage, adverse side effect.
2013
( 11 years old in 2024 )
Therapeutic Drugs
-
Emerging Technology Center One, Suite 212
1670 Discovery Drive
Charlottesville, VA 22911
United States
Private
developerpeptide therapeutic drugtheir pharmacodynamic propertytheir proprietary platform technologylifeconvenient dosingreduce side effectwell compliancepatientwell treatmentlow dosageadverse side effect
* We use standard office opening hours in near RioGin's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
RioGin is Drug Discovery business from United States that founded in 2013 (11 years old in 2024), RioGin business is focusing on Therapeutic Drugs.
RioGin headquarter office and corporate office address is located in Emerging Technology Center One, Suite 212 1670 Discovery Drive Charlottesville, VA 22911 United States.
RioGin was founded in United States.
In 2024, RioGin is currently focus on therapeutic drugs sector.
Above is snippet of Google Trends for "therapeutic drugs" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with RioGin, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
